Massimo Marignani

3.2k total citations
92 papers, 2.1k citations indexed

About

Massimo Marignani is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Massimo Marignani has authored 92 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 40 papers in Hepatology and 35 papers in Surgery. Recurrent topics in Massimo Marignani's work include Liver Disease Diagnosis and Treatment (26 papers), Helicobacter pylori-related gastroenterology studies (26 papers) and Hepatitis C virus research (19 papers). Massimo Marignani is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Helicobacter pylori-related gastroenterology studies (26 papers) and Hepatitis C virus research (19 papers). Massimo Marignani collaborates with scholars based in Italy, United States and Japan. Massimo Marignani's co-authors include Bruno Annibale, Gianfranco Delle Fave, Cesare Bordi, Stefano Angeletti, Vito D. Corleto, G. D’Ambra, Carola Severi, G. Delle Fave, Annunziata Scirocco and Bruno Monarca and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Massimo Marignani

92 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Marignani Italy 28 942 714 441 360 333 92 2.1k
Byung Ik Jang South Korea 28 943 1.0× 778 1.1× 532 1.2× 158 0.4× 587 1.8× 180 2.5k
Jean–Claude Rambaud France 25 852 0.9× 493 0.7× 606 1.4× 102 0.3× 234 0.7× 52 2.6k
Zongming E. Chen United States 22 609 0.6× 613 0.9× 121 0.3× 329 0.9× 172 0.5× 34 2.5k
Min Jae Yang South Korea 20 474 0.5× 244 0.3× 152 0.3× 122 0.3× 386 1.2× 121 1.4k
Parakkal Deepak United States 27 832 0.9× 1.1k 1.5× 273 0.6× 67 0.2× 113 0.3× 209 2.5k
P. Rolny Sweden 19 973 1.0× 667 0.9× 320 0.7× 372 1.0× 540 1.6× 46 1.9k
Cesare Ruffolo Italy 25 979 1.0× 498 0.7× 222 0.5× 60 0.2× 310 0.9× 118 2.0k
Norihisa Ishimura Japan 32 1.8k 2.0× 631 0.9× 683 1.5× 498 1.4× 654 2.0× 177 3.4k
P. Pola Italy 23 833 0.9× 253 0.4× 379 0.9× 241 0.7× 125 0.4× 71 1.8k
Mariabeatrice Principi Italy 30 1.1k 1.1× 666 0.9× 580 1.3× 186 0.5× 284 0.9× 125 2.3k

Countries citing papers authored by Massimo Marignani

Since Specialization
Citations

This map shows the geographic impact of Massimo Marignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Marignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Marignani more than expected).

Fields of papers citing papers by Massimo Marignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Marignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Marignani. The network helps show where Massimo Marignani may publish in the future.

Co-authorship network of co-authors of Massimo Marignani

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Marignani. A scholar is included among the top collaborators of Massimo Marignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Marignani. Massimo Marignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biselli, Maurizio, Massimo Iavarone, Matteo Renzulli, et al.. (2024). Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 16(6). 1080–1080. 2 indexed citations
2.
Stroffolini, Tommaso, Alessia Ciancio, Alessandro Federico, et al.. (2023). Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic. European Journal of Clinical Microbiology & Infectious Diseases. 42(8). 945–950. 1 indexed citations
3.
Roberto, Michela, Carmen Cantisani, S Caponnetto, et al.. (2023). The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management. Frontiers in Oncology. 12. 1026978–1026978. 6 indexed citations
4.
Marignani, Massimo, et al.. (2022). COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study. World Journal of Hepatology. 14(1). 274–286. 2 indexed citations
5.
Krokidis, Μiltiadis, Marta Zerunian, Tiziano Polidori, et al.. (2021). Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features. Diagnostics. 11(6). 956–956. 12 indexed citations
6.
Morisco, Filomena, Alessandro Federico, Massimo Marignani, et al.. (2021). Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study. Cancers. 13(15). 3810–3810. 10 indexed citations
7.
Antonelli, Giulio, Elia Gigante, Massimo Iavarone, et al.. (2018). Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United European Gastroenterology Journal. 6(7). 1039–1048. 51 indexed citations
8.
9.
Mangia, Alessandra, Giovanni Cenderello, A. Orlandini, et al.. (2014). Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience. PLoS ONE. 9(10). e110284–e110284. 7 indexed citations
10.
Marignani, Massimo. (2012). ‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas. World Journal of Gastrointestinal Pharmacology and Therapeutics. 3(2). 21–21. 2 indexed citations
11.
Costanzo, Gianfranco, et al.. (2011). Hepatocellular carcinoma in a non-cirrhotic liver of a HCV-positive woman with sustained viral response. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Begini, Paola, Maria Christina Cox, Stefano Angeletti, et al.. (2011). Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: A case report. Scandinavian Journal of Infectious Diseases. 43(9). 750–752. 3 indexed citations
13.
Marzano, Alfredo, Andrea Marengo, Michela Di Fonzo, et al.. (2010). Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients. Mediterranean Journal of Hematology and Infectious Diseases. 2(1). e2010035–e2010035. 2 indexed citations
14.
Capurso, Gabriele, Massimo Marignani, Matteo Piciucchi, Elettra Merola, & Gianfranco Delle Fave. (2008). Probiotics and Severe Acute Pancreatitis. Journal of Clinical Gastroenterology. 42(Supplement 3). S148–S151. 9 indexed citations
15.
Capurso, Gabriele, Massimo Marignani, & Gianfranco Delle Fave. (2006). Probiotics and the incidence of colorectal cancer: when evidence is not evident. Digestive and Liver Disease. 38. S277–S282. 39 indexed citations
16.
Zullo, Angelo, Cesare Hassan, Vincenzo De Francesco, et al.. (2003). A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Digestive and Liver Disease. 35(4). 232–236. 85 indexed citations
17.
Marignani, Massimo. (2002). Coeliac disease and autoimmune cholangitis: a case report. Digestive and Liver Disease. 34(12). 862–865. 3 indexed citations
18.
Centanni, Marco, et al.. (1999). Atrophic Body Gastritis in Patients With Autoimmune Thyroid Disease. Archives of Internal Medicine. 159(15). 1726–1726. 1 indexed citations
19.
Angeletti, Stefano, V.D. Corleto, Orazio Schillaci, et al.. (1998). Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours. Gut. 42(6). 792–794. 61 indexed citations
20.
Annibale, Bruno, Laura de Magistris, Vito D. Corleto, et al.. (1994). Zollinger‐Ellison syndrome and antral G‐cell hyperfunction in patients with resistant duodenal ulcer disease. Alimentary Pharmacology & Therapeutics. 8(1). 87–93. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Byung Ik Jang Breakdown of academic impact, for papers by Jean–Claude Rambaud Breakdown of academic impact, for papers by Zongming E. Chen Breakdown of academic impact, for papers by Min Jae Yang Breakdown of academic impact, for papers by Parakkal Deepak Breakdown of academic impact, for papers by P. Rolny Breakdown of academic impact, for papers by Cesare Ruffolo Breakdown of academic impact, for papers by Norihisa Ishimura Breakdown of academic impact, for papers by P. Pola Breakdown of academic impact, for papers by Mariabeatrice Principi
Rankless by CCL
2026